KENNETH MCCLAIN to CD52 Antigen
This is a "connection" page, showing publications KENNETH MCCLAIN has written about CD52 Antigen.
Connection Strength
0.014
-
Anti-CD52 antibody, alemtuzumab, binds to Langerhans cells in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2005 Mar; 44(3):251-4.
Score: 0.014
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.